Suppr超能文献

标记博来霉素的主要组分被小鼠体内实体艾氏腹水瘤摄取的情况。

Uptake of main fractions of labelled bleomycin by solid Ehrlich ascites tumours in mice.

作者信息

Rembelska M, Liniecki J, Koniarek B, Krawczyk Z

出版信息

Nuklearmedizin. 1984 Jun;23(3):127-9.

PMID:6207486
Abstract

Concentrations were studied of 58Co in the solid Ehrlich ascites tumour, blood, muscle and bone of male Swiss mice administered as complexed with total bleomycin commercially available and its isolated fractions A2, B2, demethyl A2, A1, A5, B4 and bleomycinic acid. The tumour/non-tumour ratios were determined 24 hrs after injection of the complexes. The ratios for fraction A2, B2 and total bleomycin were very close to each other. The remaining fractions showed lower values of the ratios. These results suggest that it is unlikely that any of the fractions studied are superior to total labelled bleomycin with respect to tumour scintigraphy.

摘要

研究了将58Co与市售的总博来霉素及其分离组分A2、B2、去甲基A2、A1、A5、B4和博来霉素酸络合后,给予雄性瑞士小鼠,其固体艾氏腹水瘤、血液、肌肉和骨骼中58Co的浓度。注射络合物24小时后测定肿瘤/非肿瘤比率。组分A2、B2和总博来霉素的比率彼此非常接近。其余组分的比率值较低。这些结果表明,就肿瘤闪烁显像而言,所研究的任何组分都不太可能优于总标记博来霉素。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验